See also Pfizer vs. BioNTech
The world knows the Johnson & Johnson brand. It's one of the top brands on the planet and has been for decades. Most of the world doesn't know Janssen. It's logical to call it the J&J vaccine accordingly, for marketing purposes it makes a lot more sense.
If the Berkeley West Lab subsidiary of J&J produced the vaccine, nobody would call it the Berkeley West Lab vaccine.
I have a feeling that news sources are very guarded about introducing new names to the public, especially ones as difficult to pronounce as BioNTech (I've heard some great butchering of the pronunciation too).
Not everything needs to be distilled down to nationalistic undertones.
I am getting sick of this kind of discussion permeating on HN - It is extremely juvenile and damaging to the spirit of HN. In this regard, Reddit seems to be a lot better. Go on any vaccine related thread and there is absolutely none of this. There is so much more global cooperation observed on Reddit than on HN.
My complaint, beyond just the media, is that large pharma, like Pfizer, being fundamentally uninnovative companies that grow by acquisition rather than invention. And about small companies being denied the potential to grow because of an oligopoly of control.
Name brand recognition drives dollars, and in biotech the ability to raise money is just as much a hurdle as the chances of your trial failing.